View more on these topics

Call for &#39suite of simple products&#39

The Sandler review is recommending the introduction of a price capped &#39suite of simple products&#39 that can be sold without advice.
The move echoes very closely the &#39family of products&#39 former Work and Pensions secretary Alistair Darling, proposed to Money Marketing at the NAPF conference in May.
He wanted a range of products with minimum of safeguards and simple health warnings sold through an unregulated sales process.
The Sandler review agrees, saying regulating products and de-regulating the sales process will make the market more competitive and open up savings products to the masses.
The suite of products dubbed &#39stakeholder&#39, will include a mutual fund or unit linked life fund, a pension and a with-profits product. A protection product could also be in the included.
These products would have capped charges, a restricted investment profile to limit risk and regulated early exit charges.
With-profits products in the suite will have to be smoothing accounts managed on a 100/0 basis with explicit charges.
The salesman would have to provide pre-sale warnings on the risks involved. People on low incomes above a certain age and those with access to occupational schemes will be steered away from the pension product.
But Sandler says there would be no imperative for the salesman to be FPC qualified, &#39know their customer&#39 or provide &#39suitable advice&#39.
Clerical Medical pensions strategy manager Nigel Stammers says: “Sandler has recognised the 1 per cent is too costly for two sets of regulation and is splitting the market. There is now more incentive for the banks and supermarkets to sell in this market, but there isn&#39t for the consumer to buy.”


Threadneedle Investments – Threadneedle Global Healthcare Fund

Tuesday, July 9, 2002Type: OeicAim: Growth by investing in pharmaceutical companies,biotechnology, healthcare providers, medical supply companies andproducers of advanced medical devicesMinimum investment: Lump sum £2,000Investment split: Pharmaceuticals 55.5%, healthcare 14%,biotechnology 9.5%, medical technology 7%, medical supplies 8.5%,cash 5.5%Isa link: YesPep transfers: YesCharges: Initial 3.75%, annual 1.5%Commission: Initial 3%, renewal 0.5%Tel: 0800 0684000

FSA ring fenced budget for consumer education says Sandler

The FSA&#39s budget for consumer education should be ringfenced and increased according to the Sandler review.The review team wants the regulator to put together a long term plan for delivering clearly specified objectives. It also suggests that the FSA establish a separate governance structure for education such as a sub-board accountable to the main board […]

Threadneedle appoints Holden to new team for UK equities

Threadneedle Investments has recruited Mark Holden onto its new UK equities high alpha team.The team will manage UK equities for both retail and institutional clients, and will include the UK select growth fund. It will be lead by Paul Findley, and will include Peter Wilton, Steve Hewitt and Mark Holden.Holden, who joins in September, is […]

Abbey goes for eighth issue

Abbey National has introduced safety plus growth 8, a guaranteed equity bond that provides minimum growth of 20 per cent and maximum growth of 55 per cent.The bond is linked to the FTSE 100 index through a Dublin-based company called Quaich Investments 7 and there is also an Isa version of the product. Both versions […]


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers. Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm